DE60324704D1 - Wundverband enthaltend komplexe von vanadat und organische verbindungen - Google Patents

Wundverband enthaltend komplexe von vanadat und organische verbindungen

Info

Publication number
DE60324704D1
DE60324704D1 DE60324704T DE60324704T DE60324704D1 DE 60324704 D1 DE60324704 D1 DE 60324704D1 DE 60324704 T DE60324704 T DE 60324704T DE 60324704 T DE60324704 T DE 60324704T DE 60324704 D1 DE60324704 D1 DE 60324704D1
Authority
DE
Germany
Prior art keywords
wundband
vanadat
organic compounds
containing complexes
tyrosine phosphatase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60324704T
Other languages
English (en)
Inventor
Patrick Trotter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johnson and Johnson Medical Ltd
Original Assignee
Johnson and Johnson Medical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson and Johnson Medical Ltd filed Critical Johnson and Johnson Medical Ltd
Application granted granted Critical
Publication of DE60324704D1 publication Critical patent/DE60324704D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/20—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing organic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Junction Field-Effect Transistors (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
DE60324704T 2002-12-12 2003-12-08 Wundverband enthaltend komplexe von vanadat und organische verbindungen Expired - Lifetime DE60324704D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0229012A GB2396106B (en) 2002-12-12 2002-12-12 Wound dressings comprising enzyme inhibitors
PCT/GB2003/005336 WO2004052412A1 (en) 2002-12-12 2003-12-08 Wound dressings comprising vanadate complexed with organic ligands

Publications (1)

Publication Number Publication Date
DE60324704D1 true DE60324704D1 (de) 2008-12-24

Family

ID=9949580

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60324704T Expired - Lifetime DE60324704D1 (de) 2002-12-12 2003-12-08 Wundverband enthaltend komplexe von vanadat und organische verbindungen

Country Status (7)

Country Link
US (1) US20060165761A1 (de)
EP (1) EP1569697B1 (de)
AT (1) ATE413893T1 (de)
AU (1) AU2003292389A1 (de)
DE (1) DE60324704D1 (de)
GB (1) GB2396106B (de)
WO (1) WO2004052412A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0328157D0 (en) 2003-12-04 2004-01-07 Imp College Innovations Ltd Compounds
US9463119B2 (en) 2007-01-18 2016-10-11 Abigo Medical Ab Wound dressing with a bacterial adsorbing composition and moisture holding system
EP1949894B1 (de) * 2007-01-25 2016-06-29 Roche Diagnostics GmbH Verstärkung von vanadiumhaltigen Phosphatasehemmern mit Polyole
US8008035B2 (en) 2007-01-25 2011-08-30 Roche Diagnostics Operations, Inc. Enhancement of vanadium-containing phosphatase inhibitors
WO2009061270A1 (en) * 2007-11-05 2009-05-14 Abigo Medical Ab Device for the treatment of vaginal fungal infection
US8263115B2 (en) * 2008-09-11 2012-09-11 Abigo Medical Ab Method and a product to reduce and treat problems associated with tinea pedis
US10893983B2 (en) 2008-12-03 2021-01-19 Abigo Medical Ab Method for dressing a wound
GB201103898D0 (en) * 2011-03-08 2011-04-20 Univ Cardiff Molecular targets for healing or treating wounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5300496A (en) * 1991-09-30 1994-04-05 The University Of British Columbia Complexed vanadium for the treatment of diabetes mellitus
GB9323884D0 (en) * 1993-11-19 1994-01-05 Eisai London Res Lab Ltd Physiological modulation
US5871779A (en) * 1994-01-18 1999-02-16 Mount Sinai Hospital Corporation Treatment of arthropathies with vanadate compounds or analogues thereof
US5741777A (en) * 1995-10-31 1998-04-21 Board Of Regents, The University Of Texas System Modulation of wound contraction by blocking protein tyrosine phosphatase
US20020019412A1 (en) * 1998-03-12 2002-02-14 Henrik Sune Andersen Modulators of protein tyrosine phosphatases (ptpases)

Also Published As

Publication number Publication date
EP1569697B1 (de) 2008-11-12
WO2004052412A1 (en) 2004-06-24
GB2396106B (en) 2006-11-15
GB2396106A (en) 2004-06-16
EP1569697A1 (de) 2005-09-07
AU2003292389A1 (en) 2004-06-30
GB0229012D0 (en) 2003-01-15
US20060165761A1 (en) 2006-07-27
ATE413893T1 (de) 2008-11-15

Similar Documents

Publication Publication Date Title
TR199801569T2 (xx) Serin proteaz inhibit�rleri.
DE69717268T2 (de) M-amidinophenyl-analoga als faktor-xa-inhibitoren
ATE316785T1 (de) Jak-3 hemmer zur behandlung von allergischen störungen
SE9701162D0 (sv) New use II
DE602005022936D1 (de) Pyrrolidine als inhibitoren von iap
ATE409485T1 (de) Pharmazeutische zusammensetzungen inhibitoren von fab i und weitere antibiotika enthaltend
ATE399547T1 (de) Verwendung von cyclooxygenase-2 inhibitoren zur behandlung und vorbeugung von neoplasia
ATE387444T1 (de) Substituierte pyrroline als kinase inhibitoren
DE69813241T2 (de) Vielschichtiger wundverband
ATE369363T1 (de) Antibiotika mit doppelwirkung
DE60324704D1 (de) Wundverband enthaltend komplexe von vanadat und organische verbindungen
NO20050640L (no) Rutenium anticancer komplekser
DE60212613D1 (de) Doxycyclin zur behandlung von akne
DE60105025D1 (de) Pharmazeutische verbindungen zur behandlung von chronisch-obstruktiver bronchopneumonie
ATE181925T1 (de) Hemmstoffe für kathepsin-g und elastase zur verhütung von bindegewebsabbau
ATE239500T1 (de) Kombination von angiotensing-convertin-enzyme hemmern mit diuretikum zur behandlung von störungen der mikrozirkulation
DE69818510D1 (de) Neue verbindungen
DE60113252D1 (de) Inhibitoren von serin proteasen
DE602004031954D1 (de) Verbindungen zur behandlung von stoffwechselstörungen
ATE359283T1 (de) Substituierte pyrazinonverbindungen zur behandlung von entzündungen
SE0301883D0 (sv) New use II
DE60213365D1 (de) Verwendung von mglur5 antagonisten zur behandlung von pruritischen zuständen
EA200600549A1 (ru) Ингибиторы каспаз в качестве материала для покрытия медицинских продуктов для ингибирования рестеноза
DE60105618D1 (de) Dihydroporphyrinderivate und ihre verwendung
PT1244643E (pt) Inibidores da triptase

Legal Events

Date Code Title Description
8364 No opposition during term of opposition